Efficacy, safety, and current applications of brimonidine
- PMID: 18983225
- DOI: 10.1517/17425250802457609
Efficacy, safety, and current applications of brimonidine
Abstract
Background: The use of brimonidine to lower intraocular pressure has been the subject of considerable investigation. Variations of the initially approved drug including agents of a lower concentration (Alphagan P 0.15 and 0.1%, Allergan, Inc., Irvine, CA, USA) and a fixed-combination mating brimonidine with timolol (Combigan, Allergan) evolved the marketing and application of this therapy.
Objective: We review available evidence regarding the efficacy and side effect profile of brimonidine as well as its role in glaucoma management.
Results/conclusion: Brimonidine is an important component of topical glaucoma treatment that is most limited by local ocular intolerance.
Similar articles
-
An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.J Glaucoma. 2008 Dec;17(8):674-9. doi: 10.1097/IJG.0b013e318168f008. J Glaucoma. 2008. PMID: 19092465 Clinical Trial.
-
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.BMC Ophthalmol. 2014 Dec 19;14:161. doi: 10.1186/1471-2415-14-161. BMC Ophthalmol. 2014. PMID: 25527295 Free PMC article. Clinical Trial.
-
12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.Eur J Ophthalmol. 2005 Sep-Oct;15(5):581-90. Eur J Ophthalmol. 2005. PMID: 16167288 Clinical Trial.
-
Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.Drugs Aging. 2006;23(9):753-61. doi: 10.2165/00002512-200623090-00005. Drugs Aging. 2006. PMID: 17020399 Review.
-
[Fixed combinations of glaucoma medications].Oftalmologia. 2008;52(3):23-31. Oftalmologia. 2008. PMID: 19149113 Review. Romanian.
Cited by
-
Glaucoma management: relative value and place in therapy of available drug treatments.Ther Adv Chronic Dis. 2014 Jan;5(1):30-43. doi: 10.1177/2040622313511286. Ther Adv Chronic Dis. 2014. PMID: 24381726 Free PMC article. Review.
-
Glaucoma Surgery in Pregnancy: A Case Series and Literature Review.Iran J Med Sci. 2016 Sep;41(5):437-45. Iran J Med Sci. 2016. PMID: 27582594 Free PMC article.
-
Tautomerism in drug discovery.J Comput Aided Mol Des. 2010 Jun;24(6-7):475-84. doi: 10.1007/s10822-010-9359-z. Epub 2010 May 20. J Comput Aided Mol Des. 2010. PMID: 20490619
-
Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily.Clin Ophthalmol. 2013;7:1269-73. doi: 10.2147/OPTH.S47760. Epub 2013 Jun 25. Clin Ophthalmol. 2013. PMID: 23836956 Free PMC article.
-
A Narrative Review of the Complex Relationship between Pregnancy and Eye Changes.Diagnostics (Basel). 2021 Jul 23;11(8):1329. doi: 10.3390/diagnostics11081329. Diagnostics (Basel). 2021. PMID: 34441264 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
